Eisai Co Ltd ADR (Unsponsored) ESAIY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 1.13B
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 32.68
- Price/Sales
- 1.53
- Dividend Yield (Trailing)
- 3.41%
- Dividend Yield (Forward)
- 3.41%
- Dividend Payment Schedule
- Jun, Dec
- Total Yield
- 3.41%
Company Profile
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region, including East Asia & Global South; Europe, Middle East, Africa, Russia, Oceania (EMEA); Americas; China; and Japan. The company also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived from its American pharmaceutical business, followed by its Japanese pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 10,543
- Website
- https://www.eisai.co.jp
Valuation
|
Metric
|
ESAIY
|
|---|---|
Price/Earnings (Normalized) | 32.68 |
Price/Book Value | 1.49 |
Price/Sales | 1.53 |
Price/Cash Flow | 16.95 |
Price/Earnings
ESAIY
Financial Strength
|
Metric
|
ESAIY
|
|---|---|
Quick Ratio | 1.39 |
Current Ratio | 2.24 |
Interest Coverage | 8.27 |
Quick Ratio
ESAIY
Profitability
|
Metric
|
ESAIY
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ESAIY
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|CK%Pb<#% | LOCK|q?kp | $67B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|y&^Pnfv> | LOCK|s^ly% | $43B | |||
| Haleon PLC ADR
HLN
| LOCK|Q%@!!tm | LOCK|mg! | $40B | |||
| Zoetis Inc Class A
ZTS
| LOCK|$n^$GC< | LOCK|J@Y | $30B | |||
| Viatris Inc
VTRS
| LOCK|fqW!&$w | LOCK|?T | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|Lg$ | LOCK|mP | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|JLFy$@! | LOCK|T! | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|^vR<j@ | LOCK|&> | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|%%mpssM | LOCK|Jmmh@ | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|<&@>rk% | LOCK|Gqp | $2B |
United States